4880 — CellSource Co Income Statement
0.000.00%
Last trade - 00:00
- ¥27bn
- ¥22bn
- ¥5bn
- 89
- 10
- 51
- 48
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,612 | 1,855 | 2,922 | 4,274 | 4,511 |
Cost of Revenue | |||||
Gross Profit | 1,154 | 1,259 | 2,074 | 3,064 | 3,185 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,285 | 1,440 | 1,930 | 2,712 | 3,280 |
Operating Profit | 327 | 416 | 992 | 1,562 | 1,230 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 303 | 413 | 1,006 | 1,584 | 1,240 |
Provision for Income Taxes | |||||
Net Income After Taxes | 200 | 274 | 651 | 1,018 | 923 |
Net Income Before Extraordinary Items | |||||
Net Income | 200 | 274 | 651 | 1,018 | 923 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 200 | 274 | 651 | 1,018 | 923 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 15.3 | 14.3 | 33.9 | 53.3 | 47.6 |
Dividends per Share | |||||
Special Dividends per Share |